Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Noven Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 06/11/2008
- Report Title: Noven Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 58
Introduction
Noven Pharmaceuticals (Noven) is a specialty pharmaceutical company engaged in the discovery, development, manufacture and commercialization of prescription pharmaceutical products. The company markets a portfolio of hormone therapy products including Vivelle Dot, CombiPatch and Daytrana developed using its proprietary transdermal drug delivery technology, DOT Matrix.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Noven is focused on the development of transdermal drug delivery technology and prescription transdermal products. Vivelle Dot, CombiPatch and Daytrana are the company's lead transdermal products. The company has a pipeline of drugs which it develops through its collaborators and licensees.
The company's total revenues increased at a CAGR of 2% during 2002-2006, from $55 million to $61 million mainly due to revenues recognized under product sales, contract fees, royalty and milestone payments from licensees including Novartis, Novogyne, Shire, and Aventis.
Noven's revenues are forecast to have an absolute growth of +$108 million with revenues of $61 million in 2006 increasing to $169 million in 2010 primarily due to product sales of Daytrana, Vivelle Dot, Pexeva and Stavzor and the license fees and other revenues earned in connection with the it's collaborations with Novartis, Shire and Novogyne.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Browse over 450,000 market research reports, company profile reports and company financials. Search by industry sector, or simply search market research reports or company profiles by keyword. Companiesandmarkets.com contains one of the world's largest collections of market research reports and company profiles from leading global market research report publishers and analysts. Global brands rely on companiesandmarkets.com for their strategic market research needs.
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card, Credit Card, or by Invoice.
Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
